SEARCH

SEARCH BY CITATION

References

  • 1
    Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94: 1536.
  • 2
    La Vecchia C. Epidemiology of ovarian cancer: a summary review. Eur J Cancer Prev 2001; 10: 1259.
  • 3
    Levi F, Lucchini F, Negri E, Boyle P, La Vecchia C. Cancer mortality in Europe, 1990–94, and an overview of trends from 1955 to 1994. Eur J Cancer 1999; 35: 1477516.
  • 4
    Parazzini F, Franceschi S, La Vecchia C, Fasoli M. The epidemiology of ovarian cancer. Gynecol Oncol 1991; 43: 923.
  • 5
    Risch HA. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 1998; 90: 177486.
  • 6
    Franceschi S, La Vecchia C, Booth M, Tzonou A, Negri A, Parazzini F, Trichopoulos D, Beral V. Pooled analysis of 3 European case-control studies of ovarian cancer: II, age at menarche and at menopause. Int J Cancer 1991; 49: 5760.
  • 7
    La Vecchia C, Franceschi S, Gallus G, Decarli A, Liberati A, Tognoni G. Incessant ovulation and ovarian cancer: a critical approach. Int J Epidemiol 1983; 12: 1614.
  • 8
    Negri E, Franceschi S, Tzonou A, Booth M, La Vecchia C, Parazzini F, Beral V, Boyle P, Trichopoulos D. Pooled analysis of 3 European case-control studies: I, reproductive factors and risk of epithelial ovarian cancer. Int J Cancer 1991; 49: 506.
  • 9
    Adami H-O, Hsieh C-C, Lambe M, Trichopoulos D, Leon D, Persson I, Ekbom A, Janson PO. Parity, age at first childbirth, and risk of ovarian cancer. Lancet 1994; 344: 12504.
  • 10
    Chiaffarino F, Pelucchi C, Parazzini F, Negri E, Franceschi S, Talamini R, Conti E, Montella M, La Vecchia C. Reproductive and hormonal factors and ovarian cancer. Ann Oncol 2001; 12: 33741.
  • 11
    Franceschi S, Parazzini F, Negri E, Booth M, La Vecchia C, Beral V, Tzonou A, Trichopoulos D. Pooled analysis of 3 European case-control studies of epithelial ovarian cancer: III, oral contraceptive use. Int J Cancer 1991; 49: 615.
  • 12
    Simon WE, Albrecht M, Hänsel M, Dietel M, Holzel F. Cell lines derived from human ovarian carcinomas: growth stimulation by gonadotropic and steroid hormones. J Natl Cancer Inst 1983; 70: 83984.
  • 13
    Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Lewis JLJr, Strom BL, Harlap S, Shapiro S. A case-control study of oral contraceptive use and invasive epithelial ovarian cancer. Am J Epidemiol 1994; 139: 65461.
  • 14
    Whittemore AS, Harris R, Itnyre J, Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 case-control studies—II, invasive epithelial ovarian cancers in white women. Am J Epidemiol 1992; 136: 184203.
  • 15
    Risch HA, Marrett LD, Howe GR. Parity, contraception, infertility, and the risk of epithelial ovarian cancer. Am J Epidemiol 1994; 40: 58597.
  • 16
    Vessey MP, Painter R. Endometrial and ovarian cancer and oral contraceptives-findings in a large cohort study. Br J Cancer 1995; 71: 13402.
  • 17
    La Vecchia C, Franceschi S. Oral contraceptives and ovarian cancer. Eur J Cancer Prev 1999; 8: 297304.
  • 18
    WHO. Hormonal contraception and post-menopausal hormonal therapy. Lyon: IARC, 1999.
  • 19
    Bosetti C, Negri E, Trichopoulos D, Franceschi S, Beral V, Tzonou A, Parazzini F, Greggi S, La Vecchia C. Long-term effects of oral contraceptives on ovarian cancer risk. Int J Cancer 2002; 102: 26226.
  • 20
    Harris R, Whittemore AS, Itnyre J, Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies—III, epithelial tumors of low malignant potential in white women. Am J Epidemiol 1992; 136: 120411.
  • 21
    Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Ovarian tumors in a cohort of infertile women. N Engl J Med 1994; 331: 7716.
  • 22
    Venn A, Watson L, Bruinsma F. Giles G, Healy D. Risk of cancer after use of fertility drugs with in vitro fertilisation. Lancet 1999; 354: 158690.
  • 23
    La Vecchia C, Negri E, Parazzini F, Franceschi S. Fertility drugs and breast and ovarian cancer. Lancet 1995; 346: 1628.
  • 24
    Lacey JV Jr, Mink PJ, Lubin JH, Sherman ME, Troisi R, Hartge P, Schatzkin A, Schairer C. Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA 2002; 288: 33441.
  • 25
    Bosetti C, Negri E, Franceschi S, Trichopoulos D, Beral V, La Vecchia C. Relationship between postmenopausal hormone replacement therapy and ovarian cancer. JAMA 2001; 285: 3089.
  • 26
    Anderson GL, Judd HL, Kaunitz AM, Barad DH, Beresford SA, Pettinger M, Liu J, McNeeley SG, Lopez AM; Women's Health Initiative Investigators. Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the women's health initiative randomized trial. JAMA 2003; 290: 173948.
  • 27
    Bosetti C, Negri E, Franceschi S, Pelucchi C, Talamini R, Montella M, Conti E, La Vecchia C. Diet and ovarian cancer risk: a case-control study in Italy. Int J Cancer 2001; 93: 91191.
  • 28
    La Vecchia C, Decarli A, Negri E, Parazzini F, Gentile A, Cecchetti G, Fasoli M, Franceschi S. Dietary factors and the risk of epithelial ovarian cancer. J Natl Cancer Inst 1987; 79: 6639.
  • 29
    Shu WO, Brinton LA, Gao YT, Yuan JM. Population-based case-control study of ovarian cancer in Shanghai. Cancer Res 1989; 49: 36704.
  • 30
    Bidoli E, La Vecchia C, Montella M, Maso LD, Conti E, Negri E, Scarabelli C, Carbone A, Decarli A, Franceschi S. Nutrient intake and ovarian cancer: an Italian case-control study. Cancer Causes Control 2002; 13: 25526.
  • 31
    Augustin L, Polesel J, Bosetti C, Kendall CW, La Vecchia C, Parpinel M, Conti E, Montella M, Franceschi S, Jenkins DJ, Dal Maso L. Dietary glycemic index, glycemic load and ovarian cancer risk: a case-control study in Italy. Ann Oncol 2003; 14: 788.
  • 32
    Fairfield KM, Hunter DJ, Colditz GA, Fuchs CS, Cramer DW, Speizer FE, Willet WC, Hankinson SE, Fairfield KM, Hunter DJ, Colditz GA, et al. A prospective study of dietary lactose and ovarian cancer. Int J Cancer 2004; 110: 2717.
  • 33
    Meloni GF, Colombo C, La Vecchia C, Ruggiu G, Mannazzu MC, Ambrosini G, Cherchi PL, Meloni GF, Colombo C, La Vecchia C, et al. Lactose absorption in patients with ovarian cancer. Am J Epidemiol 1999; 150: 1836.
  • 34
    Tzonou A, Hsieh C-C, Polychronopoulou A, Kaprinis G, Toupadaki N, Trichopoulou A, Karakatsani A, Trichopoulos D. Diet and ovarian cancer: a case-control study in Greece. Int J Cancer 1993; 55: 4114.
  • 35
    Bosetti C, Negri E, Franceschi S, Talamini R, Montella M, Conti E, Lagiou P, Parazzini F, La Vecchia C, Bosetti C, Negri E, Franceschi S, et al. Olive oil, seed oils and other added fats in relation to ovarian cancer (Italy). Cancer Causes Control 2002; 13: 46570.
  • 36
    Parazzini F, Chatenoud L, Chiantera V, Benzi G, Surace M, La Vecchia C. Population attributable risk for ovarian cancer. Eur J Cancer 2000; 36: 5204.
  • 37
    Lynch HT, Albano W, Black L, Lynch JF, Recabaren J, Pierson R. Familial excess of cancer of the ovary and other anatomic sites. JAMA 1981; 245: 2614.
  • 38
    Eby N, Chang-Claude J, Bishop T. Familial risk and genetic susceptibility for breast cancer. Cancer Causes Control 1994; 5: 45870.
  • 39
    Parazzini F, Negri E, La Vecchia C, Restelli C, Franceschi S. Family history of reproductive cancers and ovarian cancer risk: an Italian case-control study. Am J Epidemiol 1992; 135: 3540.
  • 40
    La Vecchia C, Parazzini F, Negri E, Dal Pino D, Franceschi S. Family history and the risk of ovarian cancer. Int J Cancer 1996; 67: 9034.
  • 41
    Negri E, Pelucchi C, Franceschi S, Montella M, Conti E, Dal Maso L, Parazzini F, Tavani A, Carbone A, La Vecchia C, Negri E, Pelucchi C, Franceschi S, et al. Family history of cancer and risk of ovarian cancer. Eur J Cancer 2003; 39: 50510.
  • 42
    European Network of Cancer Registries (ENCR). Eurocim version 4.0: European incidence database V2.3, ICD-10 dictionary. Lyon: IARC, 2001.
  • 43
    ParkinDM, MuirCS, WhelanSL, GaoYT, FerlayJ, PowellJ, eds. Cancer incidence in five continents. vol. 6. Lyon: IARC, 1992.
  • 44
    ParkinDM, WhelanSL, FerlayJ, RaymondL, YoungJ, eds. Cancer incidence in five continents. vol. 7. Lyon: IARC, 1997.
  • 45
    Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer incidence in five continents. vol. 8. Lyon: IARC, 2002.
  • 46
    Segi M. Cancer mortality for selected sites in 24 countries (1950–57). Sendai, Japan: Tohoku University of Medicine, 1960.
  • 47
    DollR, PayneP, WaterhouseJ, eds. Cancer incidence in five continents: a technical report. Berlin: Springer-Verlag, 1966.
  • 48
    Devesa SS, Donaldson J, Fears T. Graphical presentation of trends in rates. Am J Epidemiol 1995; 141: 3004.
  • 49
    La Vecchia C, Levi F, Lucchini F, Negri E, Franceschi S. Descriptive epidemiology of ovarian cancer in Europe. Gynecol Oncol 1992; 46: 20815.
  • 50
    Anonymous. Pill sales trends graphed from 37 areas around the world: population reports. Baltimore, MD: Center for Communication Programs, John Hopkins University, 1988. 8.
  • 51
    Garattini S, La Vecchia C. Perspectives in cancer chemotherapy. Eur J Cancer 2001; 37: S12847.
  • 52
    Levi F, La Vecchia C, Boyle P, Lucchini F, Negri E. Western and eastern European trends in testicular cancer mortality. Lancet 2001; 357: 18534.
  • 53
    Levi F, Lucchini F, Boyle P, Negri E, La Vecchia C. Testicular cancer mortality in eastern Europe. Int J Cancer 2003; 105: 574.
  • 54
    ESHRE Capri Workshop Group. Social determinants of human reproduction. Hum Reprod 2001; 16: 151826.
  • 55
    Tavani A, Gallus S, La Vecchia C, Dal Maso L, Negri E, Pelucchi C, Montella M, Conti E, Carbone A, Franceschi S, Tavani A, Gallus S, La Vecchia C, et al. Physical activity and risk of ovarian cancer: an Italian case-control study. Int J Cancer 2001; 91: 40711.
  • 56
    Dal Maso L, Franceschi S, Negri E, Conti E, Montella M, Vaccarella S, Canzonieri V, Parazzini F, La Vecchia C, Dal Maso L, Franceschi S, Negri E, et al. Body size indices at different ages and epithelial ovarian cancer risk. Eur J Cancer 2002; 38: 176974.